“It is time for the Trump Administration and Congressional Republicans to help make health care more affordable and accessible by reinstating the ACA tax credits for working Americans and giving patients and families greater control over their own health care decisions. It is time to reverse the Trump Administration’s health cuts that put profits over patients and restore healthy competition in the health care marketplace; address inefficiencies in the health care system and supply chain; and lower the cost of health services and prescription drugs,”
The Trump Administration and congressional Republicans should reinstate ACA tax credits, reverse health care cuts, restore competition, address inefficiencies and supply chain problems, and lower the cost of health services and prescription drugs.
Occurrences
Evidence
verified · Source version 63653 · locator 5351
It is time for the Trump Administration and Congressional Republicans to help make health care more affordable and accessible by reinstating the ACA tax credits for working Americans and giving patients and families greater control over their own health care decisions. It is time to reverse the Trump Administration’s health cuts that put profits over patients and restore healthy competition in the health care marketplace; address inefficiencies in the health care system and supply chain; and lower the cost of health services and prescription drugs,
unverified · Source version 63658 · locator unknown
Last Action Date Listed July 30, 2025 Action Mr. Schumer (for himself, Mr. Wyden, Mr. Merkley, Mrs. Shaheen, Ms. Hirono, Mr. Welch, Ms. Duckworth, Mr. Hickenlooper, Mr. King, Mr. Luján, Mr. Sanders, Mr. Reed, Mr. Van Hollen, Mr. Peters, Mr. Blumenthal, Mrs. Murray, Mr. Schatz, Mr. Whitehouse, Ms. Warren, Mr. Warner, Mrs. Gillibrand, Mr. Kaine, Mr. Schiff, Ms. Baldwin, Mr. Markey, Mr. Coons, Ms. Alsobrooks, Mr. Durbin, Mr. Padilla, Mr. Gallego, Ms. Rosen, Mr. Warnock, Ms. Smith, Mr. Kelly, Mr. Booker, Ms. Slotkin, Mr. Bennet, Mr. Kim, Ms. Cortez Masto, Ms. Cantwell, Ms. Klobuchar, Ms. Blunt Rochester, Mr. Heinrich, Mr. Fetterman, Mr. Ossoff, Ms. Hassan, and Mr. Murphy) introduced the following bill; which was read twice and referred to the Committee on Finance
unverified · Source version 63660 · locator unknown
Vote Result: Motion Rejected Amendment Number: S.Amdt. 2696 to S.Amdt. 2360 to H.R. 1 (No short title on file) Statement of Purpose: To amend the Internal Revenue Code of 1986 to extend the enhanced premium tax credits and increase the individual tax rate for taxpayers with income of $10,000,000.
unverified · Source version 63662 · locator unknown
The enhanced premium tax credits expired on December 31 due to lack of federal action. Simultaneously, premiums rose more sharply than usual at least in part as insurers across the country, Rhode Island being no exception, anticipated shifts in the uninsured and underinsured rates in their markets. Average premiums across the HSRI population increased by 101%, or $111 per person per month this year compared to last year.
verified · Source version 63664 · locator 3347
Today, President Donald J. Trump announced nine new agreements with pharmaceutical manufacturers to lower prescription drug prices for Americans in line with the lowest prices paid by other developed nations (known as the most-favored-nation, or MFN, price). The agreements bring the total number of pharmaceutical manufacturers with MFN deals to 26, covering 89% of the branded drug market.
unverified · Source version 63666 · locator unknown
The Centers for Medicare & Medicaid Services (CMS) is working to end skyrocketing drug costs as the agency announces today that all 50 states, plus the District of Columbia and Puerto Rico, have applied to participate in an initiative which provides most-favored-nation pricing for certain prescription drugs to people with Medicaid. Forty states and Puerto Rico have already signed agreements to participate in this historic program that will lower Medicaid drug costs to what other countries pay, saving an estimated $64.3 billion in taxpayer dollars over the next ten years, while preserving or enhancing beneficiaries’ quality of care.
Assessments
The verified commitment is a broad call for the Trump Administration and congressional Republicans to reinstate ACA tax credits, reverse health cuts, restore competition, address inefficiencies and supply chain issues, and lower health and prescription drug costs. The verified evidence shows Reed made this call, supporting effort, but does not prove that the full outcome was achieved or that Reed materially contributed to any enacted partial outcome. The verified White House drug-price passage shows Trump Administration action on prescription drug prices only, but it does not establish Reed's material contribution and does not cover the broader ACA tax credit and health-cut reversal commitments. Therefore delivery or partial credit is not supported.